Menu

Home
About Us
Our Technology
Our Platform
Investors
News Room
- Press release
- Publications
Other Projects
- ATT-11T: Anti cancer pro-drug
- ML-10
Contact Us

Close



Search for:

Successful completion of the POC program in the Apo-Si technology

Posted on July 11, 2017 by

Successful completion of the POC program in the Apo-Si technology

Download

Posted in press release

Contact Us

Telephone: + 972.73.239.7600
Fax: +972.3.921.57.14
E-mail: info@aposense.com

Careers

Latest news

Aposense has signed a definitive agreement with SirVir Ltd. A private company, jointly owned by Aposense, Prof. Roger D. Kornberg, and Access Industries Holdings LLC. SirVir will engage in the development and commercialization of products in the field of treatment of respiratory viral infections, based on the Apo-Si technology developed by the Company
8 Jan 2019
Notice: Convening of a Shareholders Meeting
17 Sep 2018
The Company is pleased to announce the signing of a non-binding Term Sheet with Prof. Roger D. Kornberg, who was awarded the Nobel Prize in Chemistry in 2006 and is the Scientific President of the Company and Access Industries Inc for the formation of a joint venture. The joint venture will engage in the development and commercialization of products in the field of treatment of respiratory viral infections, based on the Apo-Si technology developed by the Company
15 Aug 2018

Aposense © 2019. Privacy Policy

Home
About Us
▼
Our Technology
Our Platform
Investors
▼
News Room
▼
- Press release
- Publications
Other Projects
▼
- ATT-11T: Anti cancer pro-drug
- ML-10
Contact Us